|
TMPRSS2–ETV1
(HGNC:11876, HGNC:3490)
|
prostate cancer
(MONDO_0008315)
|
weak |
weak |
weak |
weak |
weak |
|
|
TIMP3–ALK
(HGNC:11822, HGNC:427)
|
MONDO:0005103
(MONDO:0005103)
|
strong |
strong |
moderate |
strong |
weak |
|
|
THBS1–ADGRF5
(HGNC:11785, HGNC:19030)
|
|
strong |
weak |
moderate |
strong |
weak |
|
|
TGFBR3–OGA
(HGNC:11774, HGNC:7056)
|
MONDO:0002142
(MONDO:0002142)
|
weak |
weak |
weak |
weak |
weak |
|
|
TFG–ALK
(HGNC:11758, HGNC:427)
|
MONDO:0004817
(MONDO:0004817)
|
moderate |
strong |
moderate |
strong |
weak |
|
|
TFE3–PRCC
(HGNC:11752, HGNC:9343)
|
MONDO:0017884
(MONDO:0017884)
|
strong |
strong |
moderate |
strong |
moderate |
|
|
TFE3–IGFBP7
(HGNC:11752, HGNC:5476)
|
neoplasm with perivascular epithelioid cell differentiation
(MONDO_0006359)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
TFG–MET
(HGNC:11758, HGNC:7029)
|
spindle cell sarcoma
(MONDO_0002927)
|
strong |
strong |
moderate |
strong |
weak |
|
|
TFE3–RBM10
(HGNC:11752, HGNC:9896)
|
MONDO:0005086
(MONDO:0005086)
|
strong |
weak |
moderate |
strong |
weak |
|
|
TFE3–PHF1
(HGNC:11752, HGNC:8919)
|
ossifying fibromyxoid tumor
(MONDO_0006330)
|
strong |
weak |
moderate |
strong |
weak |
|
|
TFE3–YAP1
(HGNC:11752, HGNC:16262)
|
epithelioid hemangioendothelioma
(MONDO_0015523)
|
strong |
weak |
moderate |
strong |
weak |
|
|
TFE3–EWSR1
(HGNC:11752, HGNC:3508)
|
MONDO:0011655
(MONDO:0011655)
|
strong |
weak |
weak |
strong |
weak |
|
|
TFE3–TFEB
(HGNC:11752, HGNC:11753)
|
renal cell carcinoma
(MONDO_0005086)
|
weak |
weak |
weak |
weak |
weak |
|
|
MED15–TFE3
(HGNC:14248, HGNC:11752)
|
MONDO:0006397
(MONDO:0006397)
|
strong |
weak |
moderate |
strong |
weak |
|
|
TFE3–ASPSCR1
(HGNC:11752, HGNC:13825)
|
alveolar soft part sarcoma
(MONDO_0011655)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
TFCP2–EWSR1
(HGNC:11748, HGNC:3508)
|
rhabdomyosarcoma
(MONDO_0005212)
|
moderate |
weak |
moderate |
strong |
weak |
|
|
TERT–LPCAT1
(HGNC:11730, HGNC:25718)
|
MONDO:0020634
(MONDO:0020634)
|
strong |
moderate |
strong |
strong |
weak |
|
|
TFCP2–FUS
(HGNC:11748, HGNC:4010)
|
MONDO:0005212
(MONDO:0005212)
|
strong |
moderate |
strong |
strong |
weak |
|
|
TCF7L2–VTI1A
(HGNC:11641, HGNC:17792)
|
colorectal adenocarcinoma
(MONDO_0005008)
|
strong |
moderate |
moderate |
weak |
weak |
|
|
TCF3–ZNF384
(HGNC:11633, HGNC:11955)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
strong |
strong |
strong |
weak |
|